Author: Zapata, Miguel Ãngel; Banderas GarcÃa, Sandra; Sánchez, Adrián; Falcó, Anna; Otero-Romero, Susana; Arcos, Gabriel; Velazquez-Villoria, Daniel; GarcÃa-ArumÃ, Jose
Title: Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity Cord-id: r8afpenv Document date: 2020_12_16
ID: r8afpenv
Snippet: BACKGROUND: Global pandemic SARS-CoV-2 causes a prothrombotic state without fully elucidated effects. This study aims to analyse and quantify the possible retinal microvascular abnormalities. MATERIALS AND METHODS: Case–control study. Patients between 18 and 55 years old with PCR-confirmed SARS-CoV-2 infection within the last 3 months were included. Risk stratification: group 1—mild disease (asymptomatic/paucisymptomatic); group 2—moderate disease (required hospital admission with no acute
Document: BACKGROUND: Global pandemic SARS-CoV-2 causes a prothrombotic state without fully elucidated effects. This study aims to analyse and quantify the possible retinal microvascular abnormalities. MATERIALS AND METHODS: Case–control study. Patients between 18 and 55 years old with PCR-confirmed SARS-CoV-2 infection within the last 3 months were included. Risk stratification: group 1—mild disease (asymptomatic/paucisymptomatic); group 2—moderate disease (required hospital admission with no acute respiratory distress) and group 3—severe disease (subjects who developed an acute respiratory distress were admitted in the intensive care unit and presented interleukin 6 values above 40 pg/mL). Age-matched volunteers with negative serology tests were enrolled to control group. A colour photograph, an optical coherence tomography (OCT) and an angiography using OCT centred on the fovea were performed. RESULTS: Control group included 27 subjects: group 1 included 24 patients, group 2 consisted of 24 patients and 21 participants were recruited for group 3. There were no funduscopic lesions, neither in the colour images nor in the structural OCT. Fovea-centred vascular density (VD) was reduced in group 2 and group 3 compared with group 1 and control group (control group vs group 2; 16.92 vs 13.37; p=0.009) (control group vs group 3; 16.92 vs .13.63; p=0.026) (group 1 vs group 2; 17.16 vs 13.37; p=0.006) (group 1 vs group 3; 17.16 vs 13.63 p=0.017). CONCLUSION: Patients with moderate and severe SARS-CoV-2 pneumonia had decreased central retinal VD as compared with that of asymptomatic/paucisymptomatic cases or control subjects.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute infection: 1, 2, 3, 4, 5
- ace inhibitor and acute phase: 1
- ace inhibitor and acute respiratory distress: 1, 2, 3, 4, 5
- ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- acei ace inhibitor and acute infection: 1
- active infection and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and acute phase: 1, 2, 3, 4, 5, 6, 7
- active infection and acute respiratory distress: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- active infection and acute respiratory distress syndrome develop: 1
- active infection and long term outcome: 1
- active infection and longitudinal study: 1, 2, 3, 4, 5
- acute infection and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute infection and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute phase and long frequently: 1
- acute phase and long term outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute phase and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- acute respiratory distress and long term outcome: 1, 2, 3, 4, 5, 6, 7
- acute respiratory distress and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date